Cell & Gene Therapy World 2017

Supply Chain & Logistics Hub

#

After 2017’s successful launch, we and our partners are teaming up together to empower cell therapy developers to handle the complexities of a modern supply chain.

 

Register

Raw & Starting Materials: Tuesday, January23RD

Facing up to critical raw materials supply shortfalls – the single largest elephant in the commercial cell & gene therapy room? 

  • Where specifically do/will the greatest shortfalls current exist and just how significant are they in the context of expected clinical and commercial demand over the short- to mid-term? (Eg. plasmids, cell culture media)
  • How to develop the innovation and infrastructure needed to overcome raw material supply shortages whilst minimizing Cost of Goods? (Eg. capitalizing on novel/emerging cell sources for the cell therapy industry)
     

Starting material optimization for autologous and allogeneic cell & gene therapies

  • Viral safety considerations for cell- and gene-based therapies  
  • How to manage and standardize global/multi-site apheresis? Addressing quality and consistency challenges
  • Defining best practice in allogeneic cell therapy donor supply and management
     

How to maximize efficiency in raw and starting materials quality control/characterization

  • Optimizing quality of raw and starting materials – what exactly constitutes ‘good enough’? 
  • Identifying and overcoming key challenges in raw and starting materials management for decentralized/point of care manufacturing (eg. of a CAR T cell immunotherapy)?

Cold Chain & Data Integration/Management: Wednesday, January 24TH

 Supply chain data management and integration
  • Integrated approach to management of CGT product supply chain
  • How to identify the data that is really critical to collect, and how to integrate and utilize it to the benefit of the overall supply chain?
  • Scaling up to commercial: how to automate the data management piece to allow the move from hundreds to thousands of patients?
  • Track and trace and supply chain security – how to satisfy disparate regulatory requirements and standards on a multinational basis?
  • Generic ‘off the shelf’ vs. tailored cell therapy supply chain management software – analysing the practical utility/applicability of both options

 

Tour of the Vein-to-Vein Supply Chain Hub
This session will be staged in our expanded Supply Chain hub – an experiential, circular journey along the entirety of the autologous cell-based therapy supply chain: from starting material obtainment/management through cold chain logistics, bioprocessing, quality control, fill-finish and management/ delivery to the patient back at the point of care.

  • Delivering a strategic roadmap for supply chain development and validation for patient-specific cell & gene therapies
  • How to identify/predict and minimize the potential variables in your supply chain to achieve true consistency in product quality and delivery?
  • Leveraging supply chain strategies and technology to scale from clinical to commercial volumes


Supply chain scale up strategies and enabling technologies to minimize CoGs

  • Sector leaders’ tips for designing and implementing efficient, scalable
  • cell & gene supply chains
  • Next generation cold chain technologies (including automated/closed solutions) – what real improvements are they delivering in practice? (Eg. cost, quality, configurability, flexibility and ease of integration)

Speakers Include:

Loading
18 Results

  • "The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy."
    Anne-Virginie Eggimann,
    Vice President, Regulatory Science, Bluebird Bio, Inc
  • “Great program, great people, great venue.”
    Klaus Kühlcke
    Managing Director, EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.”
    Nathalie Clement
    Associate Director, Powell Gene Therapy Center, University of Florida
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • "It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives."
    Kurt Gielen
    Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.
  • “Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.”
    Steven Goodman
    Director, Strategy and Engagement, GSK

Past Attendees

  • Attendign companies Cell & Gene Therapy World
  • Attendign companies Cell & Gene Therapy World
  • abl
  • Attendign companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • adaptim
  • Attendign companies Cell & Gene Therapy World
  • Attendign companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • aldevron
  • allele biotech attending companies
  • Attendign companies Cell & Gene Therapy World
  • Attendign companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • apogenix
  • arthrogen
  • attending pharma/biotech companies
  • Attendign companies Cell & Gene Therapy World
  • Attendign companies Cell & Gene Therapy World
  • Attendign companies Cell & Gene Therapy World
  • Attendign companies Cell & Gene Therapy World
  • Attendign companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • brainstorm
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • gcon
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • genvec
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • key biologics
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • longeveron
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • proqinase
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • takara
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • vcls
  • attending pharma/biotech companies
  • Vineti
  • Attendign Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • world care
  • attending pharma/biotech companies
  • attending pharma/biotech companies